From: Investigation of the immunogenicity of Zika glycan loop
Number | Hybridoma Supernatant Name | Mouse | Antigen |
---|---|---|---|
1 | Z10C11–3–2-1-2 | #287 | TMV-GL |
2 | Z5B5–2–1-1-2 | #287 | TMV-GL |
3 | EV4E8–6–2-3-2 | #300 | TMV-E |
4 | Z10C11–3–2-3-2 | #287 | TMV-GL |
5 | Z9B12–2–2-2-1 | #287 | TMV-GL |
6 | Z9B12–2–2-1-1 | #287 | TMV-GL |
7 | EV4E8–5–4-3-1 | #300 | TMV-E |
8 | Z5B5–2–1-3-1 | #287 | TMV-GL |
9 | Z5B5–2–1-3-2 | #287 | TMV-EGL |
10 | EV4E8–5–1-1-1 | #300 | TMV-E |
11 | EV4E8–5–4-3-2 | #300 | TMV-E |
12 | EV4E8–5–1-1-3 | #300 | TMV-E |
13 | Z9B12–2–2-2-3 | #287 | TMV-GL |
14 | Z9B12–2–2-1-1 | #287 | TMV-GL |
15 | EV4E8–6–1-3-2 | #300 | TMV-E |
16 | Z10C11–3–2-3-1 | #287 | TMV-GL |
17 | Z5B5–2–1-1-1 | #287 | TMV-GL |
18 | Z9B12–2–2-1-4 | #287 | TMV-GL |
19 | Z9B12–2–2-2-2 | #287 | TMV-GL |
20 | Z9B12–2–2-1-3 | #287 | TMV-GL |
22 | KV14H8–1–2-1 | #299 | rE |
23 | KV14H8–1–2-2 | #299 | rE |
24 | KV13A7–2–3-2 | #299 | rE |
25 | KV13A7–2–3-1 | #299 | rE |
26 | KV13A7–2–6-2 | #299 | rE |
27 | KV13A7–2–6-1 | #299 | rE |